Supply of medication for the urgent treatment of COVID-19 by community pharmacy within NHS Surrey Heartlands ICB

Concepts

• pharmacy services
• woking
• community pharmacy services
• nhs surrey heartlands icb
• community pharmacies
• community pharmacy
• nhs community pharmacy provision
• surrey heartlands icb
• surrey heartlands
• optimise treatment use

Location

South East England: Surrey

Description

Provision of antiviral medication through NHS community pharmacy provision within Surrey Heartlands ICB for the urgent treatment of COVID-19. To reduce the risk of complications from and spread of COVID-19, and to optimise treatment use by providing safe access to treatment in a timely manner to avoid clinically unacceptable delays, this specialised service is provided by a limited number of community pharmacies in Surrey Heartlands. The service is designed to cover the supply of medication following prescription of the treatment to a Surrey Heartlands patient by a clinician within the COVID medicines delivery unit. There is a requirement to start treatment quickly in line with the recommendations included in NICE TA878. CPV Code 85149000-5 - Pharmacy services, but not including community pharmacy services that are arranged under The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013

Total Quantity or Scope

Supply of medication for the urgent treatment of COVID-19 by a community pharmacy provider. The Awarding Authority intends to award a contract to an existing provider following direct award process C for a two year term from 1st April 2025 - 31st March 2027. The value of the contract is £9273.58 over the term to include IV service on call cover over weekends and bank holidays with further funding as follows: £52.28 per call out £15.68 per dispensing fee £11.50 per delivery fee

Award Detail

Award Criteria

CPV Codes

• 85149000 - Pharmacy services

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by [Add date]. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight on 16th April 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to syheartlandsicb.contractsadmin@nhs.net. The award decision-makers were members of the following forums: Medicines Optimisation Board Commissioning, Contracting and Commercial Committee Executive Team No conflicts of interest or potential conflicts of interest were noted. Key Criteria 3 Integration, collaboration and service sustainability and Key Criteria 4 Improving access, reducing health inequalities and facilitating choice were most highly weighted for this service in consideration of the urgent nature of the requirement to obtain these medications from convenient easily accessible locations and the intrinsic collaborative nature of the service across system working. Key Criteria 1 Quality & Innovation and Key Criteria 2 Value were considered important but this is a small, ring fenced service for which flexibility and innovation is less apparent and for which value is achieved. Key Criteria 5 Social Value was weighted third most highly; operational practices and employment opportunities present. The existing pharmacy contractor has consistently demonstrated adequate and sustained good delivery of services and the delivery and reporting actions required, ensuring compliance with expected standards. Their ongoing performance provides assurance regarding the continuity and reliability of future service provision.